Central serous chorioretinopathy associated with adrenal myelolipoma

Klinische Monatsblatter fur Augenheilkunde

Volumn 220, Issue 3, 2003, Pages 199-203

  Katsimpris, John M ^a   Vandoros, Makis ^b   Petropoulos, Ioannis K ^c   Andrikopoulos, Panagiotis ^b  

^a UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^b General Hospital of Aegion   (Greece)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Adrenal myelolipoma; Central serous chorioretinopathy; Epinephrine; Hypercortisolism; Systemic hypertension

Indexed keywords

STEROID;

ADRENAL TUMOR; ADULT; BLOOD PRESSURE; CASE REPORT; CENTRAL SEROUS RETINOPATHY; CLINICAL FEATURE; CONFERENCE PAPER; CUSHING SYNDROME; DISEASE ASSOCIATION; FLUORESCENCE ANGIOGRAPHY; HISTOLOGY; HUMAN; MALE; METAMORPHOSIS; MYELOLIPOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REMISSION; STEROID URINE LEVEL; VISUAL IMPAIRMENT;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; CHORIORETINITIS; DIAGNOSIS, DIFFERENTIAL; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; LIPOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; RETINAL DETACHMENT; VISION DISORDERS;

EID: 0037353471     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38187     Document Type: Conference Paper

References (44)

1. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002; 47: 431-448
2. Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999; 128: 63-68
3. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993; 111: 1229-1233
4. Jain IS, Singh K. Maculopathy a corticosteroid side-effect. J All India Ophthalmol Soc 1966; 14: 250-252
5. Quillen DA, Gass DM, Brod RD, Gardner TW, Blankenship GW, Gottlieb JL. Central serous chorioretinopathy in women. Ophthalmology 1996; 103: 72-79
6. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984; 68: 329-331
7. Harada T, Harada K. Six cases of central serous chorioretinopathy induced by systemic corticosteroid therapy. Doc Ophthalmol 1985; 60: 37-44
8. Polak BC, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1995; 79: 922-925
9. Williamson J, Nuki G. Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol 1970; 54: 405-409
10. Iida T, Spaide RF, Negrao SG, Carvalho CA, Yannuzzi LA. Central serous chorioretinopathy after epidural corticosteroid injection. Am J Ophthalmol 2001; 132: 423-425
11. Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D. Central serous chorioretinopathy associated with inhaled or intranasal cortisteroids. Ophthalmology 1997; 104: 1653-1660
12. Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 1987; 144: 46-50
13. Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina 1987; 7: 111-131
14. Werry H, Arends C. Untersuchung zur Objektivierung von Persönlichkeitsmerkmalen bei Patienten mit Retinopathia centralis serosa. Klin Monatsbl Augenheilkd 1978; 172: 363-370
15. Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol 1974; 77: 158-160
16. Gass JD. Bullous retinal detachment and multiple retinal pigment epithelial detachments in patients receiving hemodialysis. Graefes Arch Clin Exp Ophthalmol 1992; 230: 454-458
17. Thoelen AM, Bernasconi PP, Schmid C, Messmer EP. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina 2000; 20: 98-99
18. Sibayan SA, Kobuch K, Spiegel D, Eckert E, Leser R, Monzer J et al. Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelium cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2000; 238: 515-519
19. De Venecia G, Jampol LM. The eye in accelerated hypertension: II. Localized serous detachments of the retina in patients. Arch Ophthalmol 1984; 102: 68-73
20. Yannuzzi LA, Guyer DR, Green WR. The retina atlas. Part VII, Chapter 29: Pregnancy and retinal disease. St Louis: Mosby-Year Book Inc, 1995: 403
21. Ciardella AP, Guyer DR, Spitznas M, Yannuzzi LA. Central serous chorioretinopathy. In: Ryan SJ (ed): Retina. St. Louis: CV Mosby, 2001: 1153-1181
22. Jabs DA, Hanneken AM, Schachat AP, Fine SL. Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol 1988; 106: 230-234
23. Kinyoun JL, Kalina RE. Visual loss from choroidal ischemia. Am J Ophthalmol 1986; 101: 650-656
24. nd ed. St. Louis: Mosby, 1977: 28-41
25. Spitznas M. Central serous chorioretinopathy. In: Ryan SJ, Schachar AP, Murphy RP, Paty A (eds): Retina. St. Louis: CV Mosby, 1989: 217-227
26. Iida T, Hagimura N, Takahashi K, Muraoka K. Study of choroidal vascular lesions in bullous retinal detachment by indocyanine green angiography. Nippon Ganka Gakkai Zasshi 1995; 99: 945-954
27. Wada M, Yamada H, Iwashita K et al. Indocyanine green angiographic features of central serous chorioretinopathy. Rinsho Ganka (Jpn J Clin Ophthalmol) 1998; 52: 572-577
28. Katsimpris J, Donati G, Kapetanios A, Pharmakakis N, Pournaras CJ. Value of indocyanine green angiography in detection of central serous chorioretinopathy. Klin Monatsbl Augenheilkd 2001; 218: 335-337
29. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT MF-2 smooth muscle cells. J Clin Invest 1991; 88: 385-389
30. Hadcock JR, Malbon CC. Regulation of beta-adrenergic receptors by permissive hormones: glucocorticoids increase steady-state levels of receptor Mrna. Proc Natl Acad Sci USA 1998; 85: 8415-8419
31. Yard AC, Kadowitz PJ, Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. Eur J Pharmacol 1972; 20: 1-9
32. Wakakura M, Suzuki H. Central serous chorioretinopathy. Rinsho Ganka (Jpn J Clin Ophthalmol) 1979; 33: 1237-1240
33. Avci R, Deutman AF. Die Benhandlung der zentralen serösen Choroidopathie mit dem Betarezeptorenblocker Metoprolol (vorläufige Ergebnisse). Klin Monatsbl Augenheilkd 1993; 202: 199-205
34. Browing DJ. Nadolol in the treatment of central serous retinopathy. Am J Ophthalmol 1993; 116: 770-771
35. Abramowicz I. Retinochoroidopathy and adrenocortical crisis in Addison's disease. Pathological investigations. Klin Oczna 1970; 40: 99-101
36. Zamir E. Central serous retinopathy associated with adrenocorticotropic hormone therapy. A case report and hypothesis. Graefes Arch Clin Exp Ophthalmol 1997; 235: 339-344
37. Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 1997; 46: 29-37
38. Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P et al. Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 1997; 46: 107-113
39. Seppel T, Schlaghecke R. Subclinical hypercortisolism in incidentally detected adrenal adenoma. Dtsch Med Wochenschr 1996; 121: 503-507
40. Saruta T, Suzuki H, Shibata H. Adrenal incidentaloma. Nippon Naibunpi Gakkai Zasshi 1993; 69: 509-519
41. Saeger W. Pathology of adrenal neoplasms. Minerva Endocrinol 1995; 20: 1-8
42. Kanj HA, Noronha J, D'Aguillo AF, Amorosa JK, Amorosa LF. Bilateral adrenal myelolipomas with Cushing's syndrome. JAMA 1988; 259: 3034-3036
43. Bennet BD, McKenna TJ, Hough AJ, Dean R, Page DL. Adrenal myelolipoma associated with Cushing's disease. Am J Pathol 1980; 73: 443-447
44. Walker BR, Best R, Shackleton CH, Padfield PL, Edwards CR. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 1996; 27: 190-196